{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:02Z","timestamp":1750005602327,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>A child with chronic granulomatous disease on vancomycin treatment had V trough levels that became undetectable, as measured in our hospital\u2019s clinical laboratory by a commonly employed particle-enhanced turbidometric inhibition assay. An alternative laboratory method yielded appropriate results. Recognizing and resolving erroneously low V trough levels could prevent needless adjustments in dosing that could increase risk for acute kidney injury.<\/jats:p>","DOI":"10.1097\/inf.0000000000003412","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T06:00:11Z","timestamp":1637560811000},"page":"302-303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Falsely Undetectable Vancomycin Levels in a Pediatric Patient With Chronic Granulomatous Disease"],"prefix":"10.1097","volume":"41","author":[{"given":"Mariawy","family":"Riollano Cruz","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damodara Rao","family":"Mendu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Tosi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Pediatrics and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1373\/clinchem.2008.112946","article-title":"Two cases with unusual vancomycin measurements.","volume":"55","author":"Simons","year":"2009","journal-title":"Clin Chem"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1345\/aph.1R566","article-title":"Two suspected cases of immunoglobulin-mediated interference causing falsely low vancomycin concentrations with the Beckman PETINIA method.","volume":"47","author":"Gunther","year":"2013","journal-title":"Ann Pharmacother"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.7754\/Clin.Lab.2017.170304","article-title":"Undetectable vancomycin concentrations utilizing a particle enhanced turbidimetric inhibition immunoassay in a patient with an elevated IgM level.","volume":"63","author":"Cooper","year":"2017","journal-title":"Clin Lab"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/INF.0b013e31826a3eaf","article-title":"Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children.","volume":"31","author":"Gordon","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/INF.0000000000000991","article-title":"Healthcare-associated Staphylococcus aureus bacteremia in children: evidence for reverse vancomycin creep and impact of vancomycin trough values on outcome.","volume":"35","author":"McNeil","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"89, viii","DOI":"10.1016\/j.hoc.2012.11.002","article-title":"Chronic granulomatous disease.","volume":"27","author":"Holland","year":"2013","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:02Z","timestamp":1750003442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003412","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}